Sunitinib Malate

Especificaciones

341031-54-7Número CAS

638-825-9Número CE

N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acidNombre IUPAC

C26H33FN4O7Fórmula química

532.6 g/molPeso molecular

Sunitinib malate; 341031-54-7; SU011248 L-malate salt; PHA-290940AD; sunitinib L-malate; SU010398; SU-011248 L-malate salt; DTXSID4046492; LVX8N1UT73; SU-010398; DTXCID801476195; NSC736511; 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1); 1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1); RefChem:56081; Sutent; Sunitinib malate [USAN]; MFCD08282795; Sunitinib (Malate); N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acid; (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (S)-2-hydroxysuccinate; SU 11248; CAS-341031-54-7; NCGC00164631-01; UNII-LVX8N1UT73; SU 011248; Sutent;; C26H33FN4O7; PDGF TK antagonist; Sutent (TN); Sutent (TN) (Pfizer); Sunitinib Malate (Sutent); CHEMBL1567; SU-11248 L-malate salt; SUNITINIB MALATE [MI]; Sunitinib malate (JAN/USAN); SUNITINIB MALATE [JAN]; orb1225255; orb1310676; SCHEMBL1258610; Sunitinib (Malate) (Standard); SCHEMBL29371243; SUNITINIB MALATE [VANDF]; SUNITINIB MALATE [MART.]; CHEBI:232546; PNU-290940AD; SUNITINIB MALATE [WHO-DD]; HMS3261H09; HMS6018J17; Sunitinib malate, >=98% (HPLC); Tox21_112249; Tox21_500514; HY-10255R; SU-11248J; Sunitinib malate - Bio-X trade mark; AKOS005145765; AKOS025149097; Sunitinib Malate (Sunitinib L-Malate); SUNITINIB MALATE [ORANGE BOOK]; Tox21_112249_1; CCG-221818; CS-0177; EBC-218028; FS10822; KS-5023; NCGC00164631-05; NCGC00261199-01; BP-43644; BS164428; HY-10255; MS-33338; SY075040; SU-11248;; SW219407-1; D06402; Q27283213; (2S)-2-Hydroxybutanedioic acid--N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1/1); (2S)-2-hydroxybutanedioic acid; N-[2-(diethylamino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-2,4-dimethyl-1H-pyrrole-3-carboxamide; (Z)-N-(2-(diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide(S)-2-hydroxysuccinate; 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1); 1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, (2S)-hydroxybutanedioate (1:1); 1H-Pyrrole-3-carboxamide,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, malate salt; N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimehyl-1H-pyrrole-3-carboxamide malate; N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide Malate; N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-indolin-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide;(2S)-2-hydroxybutanedioic acidSinónimos